Dengue Vaccine and its three doses for full protection Dengue fever vaccine development is difficult due to the fact that DENV has four serotypes, each of which might cause sickness. A new dengue vaccine has been licenced for use in children aged 9 to 16 who have had a past laboratory-confirmed dengue virus infection and live in dengue-endemic areas. Some US territories and freely affiliated states are endemic zones. The vaccine is not recommended for use in tourists from the United States who are visiting but not living in a dengue-infested area.
Dengue vaccine requires three doses for complete protection in children.
After confirming that a patient is eligible, the first dose can be administered
Six months after the first dose, the second is given.
Six months following the second dose, the third is given.
Read More :
| https://bloggerthrive.blogspot.com/2021/12/dengue-vaccine-dengue-fever-causes.html |
